Rivaroxaban Precision Dosing Strategy for Real‐World Atrial Fibrillation Patients

Rivaroxaban Precision Dosing Strategy for Real‐World Atrial Fibrillation Patients

Rivaroxaban is a direct‐acting oral anticoagulant approved to prevent strokes in patients with atrial fibrillation. Dosage recommendations are approved for all adult patients to receive either 15 mg or 20 mg once daily depending upon renal function. There are a number of reasons to believe rivaroxab...

Full description

Saved in:
Bibliographic Details
Main Authors: Robyn Konicki (Author), Daniel Weiner (Author), J. Herbert Patterson (Author), Daniel Gonzalez (Author), Angela Kashuba (Author), Yanguang Carter Cao (Author), Anil K. Gehi (Author), Paul Watkins (Author), J. Robert Powell (Author)
Format: Book
Published: Wiley, 2020-07-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items